N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5704-5711

  Haas, Pieter Jan ^a   De Haas, Carla J C ^a   Kleibeuker, Wendy ^a   Poppelier, Miriam J J G ^a   Van Kessel, Kok P M ^a   Kruijtzer, John A W ^b   Liskamp, Rob M J ^b   Van Strijp, Jos A G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CHEMOTAXIS INHIBITORY PROTEIN OF STAPHYLOCOCCUS AUREUS; COMPLEMENT COMPONENT C5A RECEPTOR; FORMYLATED PEPTIDE RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MONOCLONAL ANTIBODY; MUTANT PROTEIN; PHENYLALANINE; RECEPTOR; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CHEMOTAXIS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; STAPHYLOCOCCUS AUREUS;

EID: 6344272749     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5704     Document Type: Article

References (33)

1. Wenzel-Seifen, K., L. Granbaum, and R. Seifert. 1991. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H: cyclosporin H is a potent and effective inhibitor of formyl peptide-induced Superoxide formation. J. Immunol. 147:1940.
2. Onuffer, J. J., and R. Horak. 2002. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends Pharmacol. Set. 23:459.
3. Prossnitz, E. R., and R. D. Ye. 1997. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:73.
4. Prossnitz, E. R., T. L. Gilbert, S. Chiang, J. J. Campbell, S. Qin, W. Newman, L. A. Sklar, and R. D. Ye. 1999. Multiple activation steps of the N-formyl peptide receptor. Biochemistry 38:2240.
5. Dalpiaz, A., M. E. Ferretti, G. Vertuani, S. Traniello, A. Scatturin, and S. Spisani. 2002. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor. Eur. J. Pharmacol. 436:187.
6. Kim-Park, W. K., M. A. Moore, Z. W. Hakki, and M. J. Kowolik. 1997. Activation of the neutrophil respiratory burst requires both intracellular and extracellular calcium. Ann. NY Acad. Sci. 832:394.
7. Carp, H. 1982. Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155:264.
8. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, and P. A. Ward. 1984. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259:5430.
9. Veldkamp, K. E., H. C. Heezius, J. Verhoef, J. A. van Strijp, and K. P. van Kessel. 2000. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate. Infect. Immun. 68:5908.
10. de Haas, C. J. C., K. E. Veldkamp, A. Peschel, F. Weerkamp, W. J. B. van Wamel, E. C. J. M. Heezius, M. J. J. G. Poppelier, K. P. M. van Kessel, and J. A. G. van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial anti-inflammatory agent. J. Exp. Med. 199:687
11. Postma, B., M. J. J. G. Poppelier, J. C. van Galen, E. R. Prossnitz, J. A. G. van Strijp, C. J. C. de Haas, and K. P. M. van Kessel. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. J. Immunol. 172:6994.
12. Bohnsack, J. F., K. Widjaja, S. Ghazizadeh, C. E. Rubens, D. R. Hillyard, C. J. Parker, K. H. Albertine, and H. R. Hill. 1997. A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J. Infect. Dis. 175:847.
13. Ye, R. D., and F. Boulay. 1997. Structure and function of leukocyte chemoattractant receptors. Adv. Pharmacol. 39:221.
14. Smith, J. A. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukocyte Biol. 56:672.
15. Smith, P. D. 1999. Neutrophil activation and mediators of inflammation in chronic venous insufficiency. J. Vasc. Res. 36(Suppl. 1):24.
16. Le, Y., Y. Yang, Y. Cui, H. Yazawa, W. Gong, C. Qiu, and S. M. Wang. 2002. Receptors for chemotactic formyl peptides as pharmacological targets. Int. Immunopharmacol. 2:1.
17. Buzzi, M., F. Vesce, M. E. Ferretti, E. Fabbri, and C. Biondi. 1999. Does formyl-methionyl-leucyl-phenylalanine exert a physiological role in labor in women? Biol. Reprod. 60:1211.
18. Meera, R., S. Anand, C. V. Ramesh, and R. Puvanakrishnan. 1999. Inhibition of neutrophil-derived lysosomal enzymes and reactive oxygen species by a novel tetrapeptide. Inflamm. Res. 48:479.
19. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495.
20. Erich, T., B. Dekker, M. De Beer, R. Torensma, and J. Verhoef. 1989. In vitro Stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas. J. Immunol. Methods 118:17.
21. Coding, J. W. 1986. Monoclonal antibodies: Principles and Practice. Academic Press, London.
22. Hunter, R. 1970. Standardization of the chloramine-T method of protein iodination. Proc. Soc. Exp. Biol. Med. 133:989.
23. Margolis, P. S., C. J. Hackbarth, D. C. Young, W. Wang, D. Chen, Z. Yuan, R. White, and J.. Trias. 2000. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene. Antimicrob. Agents Chemother. 44:1825.
24. Fu, H., C. Dahlgren, and J. Bylund. 2003. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy. Antimicrob. Agents Chemother. 47:2545.
25. Chadwick, V. S., D. M. Mellor, D. B. Myers, A. C. Selden, A. Keshavarzian, M. F. Broom, and C. H. Hobson. 1988. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand. J. Gastroenterol. 23:121.
26. Miyake, Y., T. Yasuhara, K. Fukui, H. Suginaka, T. Nakajima, and T. Moriyama. 1983. Purification and characterization of neutrophil chemotactic factors of Streptococcus sanguis. Biochim. Biophys. Acta. 758:181.
27. Gao, J. L., E. J. Lee, and P. M. Murphy. 1999. Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189:657.
28. Le, Y., P. M. Murphy, and J. M. Wang. 2002. Formyl-peptide receptors revisited. Trends Immunol. 23:541.
29. Casadevall, A., and L. Pirofski. 2001. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184:337.
30. Dalpiaz, A., M. E. Ferretti, R. Pecoraro, E. Fabbri, S. Traniello, A. Scatturin, and S. Spisani. 1999. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects. Biochim. Biophys. Acta. 1432:27.
31. Dalpiaz, A., R. Pecoraro, G. Vertuani, S. Spisani, O. Rizzuti, E. Fabbri, and A. Scatturin. 1999. Formylpeptide receptor antagonists: structure and activity. Boll. Chim. Farm. 138:44.
32. Wenzel-Seifert, K., and R. Seifert. 1993. Cyclosporin H is a potent and selective formyl peptide receptor antagonist: comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine and cyclosporins A, B, C, D, and E. J. Immunol. 150:4591.
33. Schiffmann, E., S. Aswanikumar, K. Venkatasubramanian, B. A. Corcoran, C. B. Pert, J. Brown, E. Gross, A. R. Day, R. J. Freer, A. H. Showell, and E. L. Becker. 1980. Some characteristics of the neutrophil receptor for chemotactic peptides. FEBS Lett. 117:1.